These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 163318)

  • 21. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
    Gillis S; Smith KA
    J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of polyoma-virus-induced tumor antigen(s) by macrophage migration inhibition.
    Szigeti R; Dalianis T; Klein G; Ito Y; Magnusson G
    Int J Cancer; 1982 Jul; 30(1):69-74. PubMed ID: 6288580
    [No Abstract]   [Full Text] [Related]  

  • 24. Limitations and utility of a cytolytic assay for measuring simian virus 40-induced cell surface antigens.
    Pancake SJ; Mora PT
    Cancer Res; 1976 Jan; 36(1):88-94. PubMed ID: 174816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity in polyoma oncogenesis.
    Vandeputte M; Datta SK
    Eur J Cancer (1965); 1972 Feb; 8(1):1-8. PubMed ID: 4335419
    [No Abstract]   [Full Text] [Related]  

  • 26. Receptors for immune complexes on cells within a polyoma virus-induced murine sarcoma.
    Braslawsky GR; Serban D; Witz IP
    Eur J Immunol; 1976 Aug; 6(8):579-83. PubMed ID: 185060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay.
    de Lapeyrière O; Imbert J; Cot E; Meyer G
    Bull Cancer; 1981; 68(2):101-8. PubMed ID: 6263382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro tests of inhibitory effect of progesterone on cell-mediated immunity in rats bearing a syngeneic uterine adenocarcinoma.
    Sekiya S; Kamiyama M; Takamizawa H
    J Natl Cancer Inst; 1975 Mar; 54(3):769-71. PubMed ID: 1091743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplant immunity to polyoma virus-induced tumor cells. IV. A polyoma strain defective in transplant antigen induction.
    Hare JD
    Virology; 1967 Apr; 31(4):625-32. PubMed ID: 4290194
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological detection of a polyoma-tumor-associated membrane antigen.
    Klein G; Ehlin B; Witz I
    Int J Cancer; 1979 May; 23(5):683-90. PubMed ID: 88422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen.
    Rabinowitz Z; Sachs L
    Virology; 1970 Feb; 40(2):193-8. PubMed ID: 4314867
    [No Abstract]   [Full Text] [Related]  

  • 36. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor development after polyoma infection in athymic nude mice.
    Stutman
    J Immunol; 1975 Apr; 114(4):1213-7. PubMed ID: 163861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of immunization of Syrian hamsters with tumor cells treated with glutaraldehyde on transplantation immunity and the cytotoxic effect of lymphocytes on polyoma tumor cells.
    Tomecki J
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):209-17. PubMed ID: 220931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.
    Lausch RN; Jones C; Christie D; Hay KA; Rapp F
    J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.